M
any studies have shown that the neuropathologic lesions characteristic of Alzheimer disease (AD) are already present many years before the late symptoms. Consequently, researchers have focused their interest on studying the transition between physiological brain aging and dementia, known as mild cognitive impairment (MCI). The progressive deterioration of the limbic system and the impairment of cortical areas lead to consequent deficits of memory, attention, language, visuospatial skills, and behaviour. 1 Clinical studies show that olfactory function deficits occur in about 90% of AD patients. The memory deficit is the first symptom of AD and it is related to premature atrophy of the temporomesial structures, like the hippocampus and the entorhinal cortex. 2 We hypotisezed that hippocampal volume loss and decrease in olfactory function may be potential early indices of cognitive impairment. This study aimed to evaluate the presence of olfactory deficit and hippocampal volume loss in a group of subjects with MCI and to assess the predictive value of these 2 indices as regard the evolution of MCI to clinically diagnosed AD.
MATERIALS AND METHODS

Participants
Eighteen patients (mean age, 68.05 ± 3.5 y; range, 55 to 85 y; 9 women and 9 men) presented with subjective memory complaints to the Alzheimer Unit of the Geriatric Department of La Sapienza, University of Rome. These patients met study's criteria for amnesic MCI without dementia and they were followed at 1 year. The study was conducted according to the guidelines on biomedical research involving human subjects (Declaration of Helsinki). Informed consent was obtained from each patient. Inclusion criteria were age 55 to 85 years, cognitive impairment of Z6 months and r10 years, and Mini Mental State Examination (MMSE) score of Z23/30 and <27/30. This score of MMSE identifies subjects with probable MCI and corresponds to the score of 0.5 (borderline cognitive function) of Clinical Dementia Rating Scale. 3 Exclusion criteria were a diagnosis of other neurodegenerative and cerebrovascular disease predisposing MCI conversion to AD. Patients with previous maxillofacial surgery, pathologies of the nose and paranasal sinuses, were also excluded.
Procedures
At baseline, a completed history and a physical, otorhinolaryngological, and neurological examination were performed. All patients underwent neuropsychological evaluation, magnetic resonance imaging (MRI) brain scan, and laboratory tests. The diagnosis of dementia was based on Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition criteria and possible or probable AD on National Institute of Neurological and Communicative Disorders and Stroke and the Alzheimer's Disease and Related Disorders Association criteria. 4 The endpoint of conversion to AD required the score of Clinical Dementia Rating Scale >1, corresponding to cognitive impairment. The olfactory function was evaluated using the Sniffin Sticks Extended Test. The Sniffin' Sticks Extended Test employs 112 felt-tip pens to evaluate odor threshold, discrimination, and identification. The total "thresholddiscrimination-identification" (TDI) score is represented by the sum of the scores from the 3 subtests and it classifies subjects in normosmic, hyposmic (TDIr30.5), and anosmic (TDIr15.5). 5 Neuroradiologic images were acquired using a 1-T MRI scanner (Gyroscan NT; Philips Medical Systems, Best, the Netherlands; release 12.1.1.1). A 3-dimensional T1 TFE sequence was acquired (TR = 18 ms, TE = 6.9 ms, flip angle = 25 degrees, pixel size = 1.31Â 1.34Â1 mm). After the scan, the images were transferred to a workstation where special software measured the area of each slice: first the right then the left hippocampus in laterolateral (sagittal) projection. The volumes were measured with the manual segmentation of hippocampal borders using the segmentation protocol of Watson et al. 6 Neuroradiologic images and manual segmentation of hippocampus were performed in blindly by 2 independent investigators. Once the area was measured, the volume was calculated in cubic centimetres (normal values 3.44 ± 0.27). 6 
Statistical Analysis
The hypothesized predictor variables were TDI and hippocampal volume. Statistical analysis was performed using STATA 11. Logistic regression analyses were conducted to assess the predictors' incremental effect on the probability of conversion to AD by 1-year follow-up. The 1-year follow-up duration was chosen to evaluate clinically relevant short-term conversion to AD. Optimal sensitivity and specificity values were calculated from receiver operating characteristic (ROC) curves. Area under the ROC curve was used for accuracy estimate. To compare ROC curves, the w 2 test was used. The interrater reliability was tested by Fleiss k. The intrarater reliability was assessed by Spearman correlation coefficient.
RESULTS
Of the 18 amnestic mild cognitive impairment (aMCI) patients recruited, 13 were nonconverters and 5 converters at T1. Of the 5 converters, 4 had probable AD and 1 had possible AD. Mean hippocampal volume and mean scores on TDI and MMSE at T0 and T1 in 18 aMCI patients, in 13 nonconverters and 5 converters are reported in Table 1 . Baseline cognitive test, TDI scores, and hippocampal volumes decreased at T1 in converters to AD. Sixteen aMCI patients presented hippocampal atrophy. Twelve aMCI patients showed olfactory deficit associated to hippocampal volume loss, 4 aMCI patients only hippocampal volume loss, 1 aMCI patient only olfactory deficit, and 1 aMCI patient had normal olfactory function and hippocampal volume (Fig. 1) . In the converter group all patients showed olfactory deficit associated to hippocampal volume loss. The estimated conversion rate from aMCI to AD after the follow-up period is 28.8% for the entire sample. The sensitivity and the specificity of the TDI were 92.3% and 75%, respectively (area under ROC curve = 0.83 ± 0.17). The sensitivity and the specificity of the hippocampal volume were 92.3% and 60%, respectively (area under ROC curve = 0.69 ± 0.12). The combination of TDI and MRI hippocampal volume, by means of a logit transformation, is as good as the 2 single tests in differentiating the disease status (area under ROC curve = 0.83 ± 0.10). The ROC curves comparison was not statistically significant, thus indicating an overall discriminating equivalency among TDI, MRI hippocampal volume, and their combination. 
CONCLUSIONS
The results confirmed the high frequency of olfactory deficits and hippocampal atrophy in MCI patients. In our study, the converters group presented olfactory deficit associated with hippocampal atrophy, compared with the nonconverters group. We did not find a statistically significant correlation between olfactory deficit and hippocampal atrophy. It may be hypothesized that reduction in hippocampal volume appears at the earliest stages of the disease. Then, with the expansion of neuronal damage in all cortical areas, olfactory deficits begin to occur. 7 Decrease in olfactory function could be considered a type of early agnosia. The destruction of the brain areas devoted to olfactory memory leads to a lack of awareness of olfactory recollections and therefore difficulty in recognizing different odours and different types of olfactory stimuli. This specific type of agnosia seems to precede the agnosia caused by a widespread decline in cognitive functions. 8 The strength of the study is in the results obtained with the Sniffin Sticks, whereas the findings reported in the literature were mainly with the University of Pennsylvania Smell Identification Test. The study has several limitations. First, the observations were conducted in a group of amnestic MCI so the results may not be applicable to other subcategories of MCI. Second, the small number of participants may limit the statistical significance of the results; however, the small sample size reflects the explorative goal of the study. These limitations affect the wide size of parameters' confidence intervals, like AUC for both variables and their combination. Third, although the use of a 1-T MRI scanner provides an excellent image of the hippocampal structure, it has been outdated by the new 3 T equipment currently available. However, findings allow us to hypothesize that in the preclinical phase of AD there are 2 easily detectable clinical features at the onset of symptoms: hippocampal 
